Email Newsletters

Life Sciences

Marlborough Firm ACT Hails Stem Cell Ruling

Marlborough-based Advanced Cell Technology (ACT), which is developing stem cell treatments for eye diseases, praised a recent...

Marlborough Firm Heartened By Stem Cell Decision

Marlborough-based Advanced Cell Technology (ACT), which is developing stem cell treatments for eye diseases, praised a Friday...

Genzyme MS Drug Has Setback

Genzyme, a biotechnology company with operations in MetroWest, has suffered a setback in its plans to sell...

WPI, UMass Medical To Collaborate On Army Project

Armed with a $1.9 million research and development grant, a team from Worcester Polytechnic Institute (WPI) and...
ADVERTISEMENT

Accelrys Moves Local Division To Milford

Accelrys, the California-based scientific business software maker that established a foothold in Central Massachusetts late last year...

ACT Announces 3rd European Site For Trials

Advanced Cell Technology (ACT) of Marlborough has announced a third site for the European clinical trial of...

With Clinical Trial Ongoing, RXi Losses Climb

Westborough-based RXi Pharmaceuticals, a development stage company which spun-out of Galena Biopharma Inc. in late April, reported...

Viking Systems Sold To N.Y. Firm

Medical visualization software maker Viking Systems of Westborough is being sold to an upstate New York-based firm,...
ADVERTISEMENT

Working Together:Natick’s SBH Sciences Strengthens State’s Link With Israel

When Gov. Deval Patrick traveled to Israel last year on a highly publicized trade mission, he was...

ACT’s Q2 Revenue Increases

Advanced Cell Technology (ACT) of Marlborough, a biotechnology firm working in regenerative medicine, reported increased revenue for...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA